Auriga downgrades Sequenom (Nasdaq: SQNM) from Buy to Sell. Price target lowered from $20 to $1.

Auriga analyst says, "Sequenom ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE